FDA Inspection
Mayinglong Pharmaceutical Group Co LtdMayinglong Pharmaceutical Group Co Ltd – FDA Inspection, Apr 13, 2018
Record Details
This FDA Inspection record concerns Mayinglong Pharmaceutical Group Co Ltd, with an inspection on April 13, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · afbc3f22-1afe-4d7c-b2ac-dfa83829e9db
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1051249
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Mayinglong Pharmaceutical Group Co Ltd
2| Date | Classification | Office | Project area |
|---|---|---|---|
| March 14, 2025 | VAI | Office of Inspections and Investigations | Drug Quality Assurance |
| December 11, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Mayinglong Pharmaceutical Group Co Ltd
- FDA Inspection 1264613 - 2025-03-14
- FDA Inspection 955742 - 2015-12-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.